Skip to main content

Does Jeremy Lin* Read the Cause Marketing Blog?

Or, How to Make your Company’s Facebook ‘Like’ Campaign a Little Less Gratuitous.

We all know how Facebook ‘Like’ campaigns go. Companies provide a little something-something, perhaps a donation to a cause, and people hit the ‘Like’ button and give up the crazy amount of data that Facebook collects on all of us.

But such promotions have already become pedestrian.

FlyBuys, Australia’s largest loyalty program with some 10 million cardholders and 5.5. million households, wanted to do something a little different.

FlyBuys knew that half of its members were on Facebook and it wanted to engage them there. But how to do it without resorting to a garden-variety ‘Like’ campaign?

FlyBuys created a promotion to ask members to donate 25 million points to Cancer Council Australia. That goal was met in 30 days.

The reason why has to do with the FlyBuys’ history. Since its inception in 1994, members of FlyBuys have been able to donate their points to charity partners, notably to Cancer Council Australia.

FlyBuys members knew therefore that this isn’t just a flash-in-the-pan relationship. The company has a history with the cause.

The result is that during the promotion more than 20,000 members have donated points and some 12,000 have liked the company’s Facebook page.

*I apologize for the gratuitous reference to the Linsational young point guard for the New York Knicks.

Comments

Popular posts from this blog

Pimping for Constant Contact

OK, not pimping really. More like a gentle noodge to nonprofits and the companies that love them that it’s time to start email marketing.

I was invited to a local presentation on email marketing from Constant Contact, the Waltham, Massachusetts email marketing outfit whose target market is small businesses and nonprofits.

They offer a cause-related marketing campaign called Care4Kids meant to benefit children’s causes. Constant Contact customers are invited to nominate worthy 501(c)(3) children’s charities to receive a free account along with the training to create an effective email campaign.

Non children’s charities are probably still eligible for charity discounts. If you’re outside the United States you might be able to induce Constant Contact to consider your cause. Alternately, you could suggest a similar program to email marketing vendors in your home country.

It goes without saying… I hope… that every nonprofit needs an email marketing component. Email marketing is a good deal lik…

The Alden Keene Cause Marketing Stock Index Dramatically Outperforms Other Indices

There are stock indexes galore; the Dow, S&P 500, the NASDAQ Composite, the Wilshire 5000, the FTSE, and hundreds more. But how would an index of the stocks of companies that do a meaningful amount of cause marketing perform compared to those well-known indexes? Pretty well, as it turns out.

I first floated the idea of a stock index that would track companies that do cause marketing back in 2009. I tried to figure out Yahoo Pipes so that I could put the feed right into this blog. But alas sometimes the geek gene does fall pretty far from the tree.

So I talked to programmers to see if I could find someone who could do the same, but it was always more than I was willing to pay.

Finally, last week I hired a MBA student to do it all in a spreadsheet, and what do you know but that over the last 15 years a basket of 25 cause marketing stocks dramatically outperforms the Dow, the S&P 500, the NASDAQ Composite, and the Wilshire 5000.

The index, which I call the Alden Keene Cause Market…

Batting Your Eyelashes at Prescription Drug Cause Marketing

I’m a little chary about making sweeping pronouncements, but I believe I've just seen the first cause marketing promotion in the U.S. involving a prescription drug.

The drug is from Allergan and it’s called Latisse, “the first and only FDA-approved prescription treatment for inadequate or not enough eyelashes.” The medical name for this condition is hypotrichosis.

Latisse is lifestyle drug the way Viagra or Propecia are. That is, no one’s going to die (except, perhaps, of embarrassment) if their erectile dysfunction or male pattern baldness or thin eyelashes go untreated.

Which means the positioning for a product like Latisse is a little tricky. Allergan could have gone with the sexy route as with Viagra or Cialis and showed lovely women batting their new longer, thicker, darker eyelashes. But I’ll bet that approach didn’t test well with women.

(I’m reminded of a joke about the Cialis ads from a comedian whose name I can’t recall. He said, “Hey if my erection lasts longer than 3 hours…